251 related articles for article (PubMed ID: 26054044)
1. Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.
Pruitt R; DaSilva NS; Cappellano A; Belessiotis C; Diez B; Gardner S; Allen J; Weinblatt M; Gottardo N; Dhall G; Finlay JL
Pediatr Blood Cancer; 2015 Nov; 62(11):1920-4. PubMed ID: 26054044
[TBL] [Abstract][Full Text] [Related]
2. Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT).
Calaminus G; Andreussi L; Garré ML; Kortmann RD; Schober R; Göbel U
Klin Padiatr; 1997; 209(4):222-7. PubMed ID: 9293454
[TBL] [Abstract][Full Text] [Related]
3. Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
da Silva NS; Cappellano AM; Diez B; Cavalheiro S; Gardner S; Wisoff J; Kellie S; Parker R; Garvin J; Finlay J
Pediatr Blood Cancer; 2010 Mar; 54(3):377-83. PubMed ID: 20063410
[TBL] [Abstract][Full Text] [Related]
4. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL
Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020
[TBL] [Abstract][Full Text] [Related]
5. [Treatment outcome of primary central nervous system germ cell tumors after combined therapy: a report of 23 cases].
Yang QY; Sun XF; Huang HQ; Zhen ZJ; Xia Y; Cai QQ; Ling JY
Ai Zheng; 2008 Apr; 27(4):438-41. PubMed ID: 18423134
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.
Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y
J Neurosurg Pediatr; 2018 Nov; 23(3):317-324. PubMed ID: 30497152
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study.
Balmaceda C; Heller G; Rosenblum M; Diez B; Villablanca JG; Kellie S; Maher P; Vlamis V; Walker RW; Leibel S; Finlay JL
J Clin Oncol; 1996 Nov; 14(11):2908-15. PubMed ID: 8918487
[TBL] [Abstract][Full Text] [Related]
9. CNS germ cell tumors: pattern of failure and effects of radiation volume.
Chitapanarux I; Lorvidhaya V; Kamnerdsupaphon P; Goss B; Ford J
J Med Assoc Thai; 2006 Apr; 89(4):415-21. PubMed ID: 16696383
[TBL] [Abstract][Full Text] [Related]
10. Potential role of ventricular tumor markers in CNS germ cell tumors.
Legault G; Allen JC
Pediatr Blood Cancer; 2013 Oct; 60(10):1647-50. PubMed ID: 23788492
[TBL] [Abstract][Full Text] [Related]
11. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.
Murray MJ; Bailey S; Heinemann K; Mann J; Göbel UK; Saran F; Hale JP; Calaminus G; Nicholson JC
Int J Cancer; 2017 Aug; 141(3):621-635. PubMed ID: 28463397
[TBL] [Abstract][Full Text] [Related]
12. Multimodality therapy for CNS mixed malignant germ cell tumors (MMGCT): results of a phase II multi-institutional study.
Robertson PL; Jakacki R; Hukin J; Siffert J; Allen JC
J Neurooncol; 2014 May; 118(1):93-100. PubMed ID: 24700239
[TBL] [Abstract][Full Text] [Related]
13. Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy.
Breen WG; Blanchard MJ; Rao AN; Daniels DJ; Buckner JC; Laack NNI
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28695992
[TBL] [Abstract][Full Text] [Related]
14. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
[TBL] [Abstract][Full Text] [Related]
15. [Germ-cell tumors of the central nervous system in childhood: retrospective study of 13 patients].
Voirin J; Klein O; Chastagner P; Moret C; Vignaud JM; Auque J; Marchal JC
Neurochirurgie; 2008 Apr; 54(2):55-62. PubMed ID: 18355878
[TBL] [Abstract][Full Text] [Related]
16. Re-induction chemotherapy regimens in patients with recurrent central nervous system mixed malignant germ cell tumors.
Abu Arja MH; Stanek JR; Finlay JL; AbdelBaki MS
Childs Nerv Syst; 2018 Nov; 34(11):2179-2186. PubMed ID: 30076436
[TBL] [Abstract][Full Text] [Related]
17. AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89.
Calaminus G; Bamberg M; Harms D; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
Neuropediatrics; 2005 Apr; 36(2):71-7. PubMed ID: 15822019
[TBL] [Abstract][Full Text] [Related]
18. Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015.
Gittleman H; Cioffi G; Vecchione-Koval T; Ostrom QT; Kruchko C; Osorio DS; Finlay JL; Barnholtz-Sloan JS
J Neurooncol; 2019 Jun; 143(2):251-260. PubMed ID: 31025275
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
Calaminus G; Frappaz D; Kortmann RD; Krefeld B; Saran F; Pietsch T; Vasiljevic A; Garre ML; Ricardi U; Mann JR; Göbel U; Alapetite C; Murray MJ; Nicholson JC
Neuro Oncol; 2017 Nov; 19(12):1661-1672. PubMed ID: 29048505
[TBL] [Abstract][Full Text] [Related]
20. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
